Lincoln Pharmaceuticals Limited

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023-04 to 2024-03🗂️ Report periods on file: 2023-04 to 2024-03

In its 2023-04 to 2024-03 reporting, Lincoln Pharmaceuticals Limited disclosed greenhouse gas emissions of 11.8K tCO2e (Scope 1 & 2). By scope: Scope 1: 3.8K Metric tonnes of CO2 equivalent; Scope 2: 8.1K Metric tonnes of CO2 equivalent; Scope 3: 2.1K Metric tonnes of CO2 equivalent. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
11.8K tCO2e (Scope 1 & 2)
2023-04 to 2024-03
💧
Water Usage
19.3K kilolitres
2023-04 to 2024-03
♻️
Waste
69.410 metric tonnes
2023-04 to 2024-03

📊 Emissions by Scope (2023-04 to 2024-03)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).3.8K Metric tonnes of CO2 equivalent
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.8.1K Metric tonnes of CO2 equivalent
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).2.1K Metric tonnes of CO2 equivalent

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

📅 Medium-term

  • Water waste reduction and Health & wellbeing of employees and workers by 2030

🌱 ESG Focus Areas

Product QualityHuman RightsEmployee SafetyBusiness EthicsCorporate GovernanceClimate Change

⚠️ Challenges & Risks +

  • Product Quality risks impacting patient health and safety
  • Human rights risks leading to reputational damage
  • Employee safety risks due to hazardous chemicals
  • Unethical business practices damaging reputation
  • Climate change risks affecting operations and profits

📋 Report Information

Reporting Period: 2023-04 to 2024-03